Nanoemulsion adjuvanted COBRA HA vaccine enhances protective antibody titers against H1N1 and H3N2 influenza viruses. [PDF]
Thomas MH, Ross TM.
europepmc +1 more source
Computational Design and Expression of Headless Influenza Hemagglutinin Antigens Toward a Modular Universal Nanoparticle Vaccine. [PDF]
Ovchinnikov V, Karplus M.
europepmc +1 more source
Distinct Humoral Response Development to Measles Virus Across Vaccine Platforms. [PDF]
Chan AKP +5 more
europepmc +1 more source
Acquisition of specific human respiratory tract binding by 2.3.4.4b H5N1 hemagglutinins requires multiple mutations. [PDF]
Ríos Carrasco M +6 more
europepmc +1 more source
Molecular Characterization of Influenza A(H3N2) Hemagglutinin Variants Circulating in Western Mexico, 2022. [PDF]
Hernandez-Gonzalez KM +6 more
europepmc +1 more source
Recombinant EHV-1 Vector Expressing Immunodominant Hemagglutinin Protein of Equine Influenza Virus H3N8 (Sub-Lineage Florida Clade 2). [PDF]
Bera BC +15 more
europepmc +1 more source
Safety and immunogenicity of a COVID-19-Influenza Combination nanoparticle vaccine (CIC) containing SARS-CoV-2 recombinant spike and quadrivalent influenza hemagglutinin with Matrix-M® adjuvant: A phase 1/2 clinical trial. [PDF]
Shinde V +11 more
europepmc +1 more source
Diminished sialoside binding in novel H5N1 influenza hemagglutinin variants identified in a human patient. [PDF]
Ni JH +9 more
europepmc +1 more source
Preexisting IgG forms immune complexes and links local thermal reactogenicity with immunogenicity in influenza vaccination. [PDF]
Hirsiger JR +4 more
europepmc +2 more sources
A bispecific antibody targeting conserved hemagglutinin epitopes confers broad protection against H7 avian influenza and accelerates viral clearance via localized respiratory delivery. [PDF]
Wu H +10 more
europepmc +1 more source

